ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,763Medicare Part D Prescriptions Filled, Including Refills

Rank: 183 out of 1031

$696K Total Retail Price of All Prescriptions

Rank: 205 out of 1031

535 Patients Receiving at Least One Drug in Part D
29% Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Alabama
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

33% of this provider’s 535 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

56% of this provider’s 535 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

13% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,975 461 295 S3 1 1
ALPRAZOLAM 1,438 169 210 B 2 12
CARISOPRODOL 1,169 94 144 R 3 91
OXYCODONE HCL 660 55 92 S2 4 101
ZOLPIDEM TARTRATE 396 115 66 5 20
OMEPRAZOLE 380 59 84 6 2
OXYCODONE HCL-ACETAMINOPHEN 370 51 75 S2 7 92
GABAPENTIN 354 83 75 8 11
CLONAZEPAM 336 71 53 B 9 29
MELOXICAM 258 80 83 10 16
LISINOPRIL 258 95 54 10 6
CITALOPRAM HBR 241 51 58 12 18
NEXIUM 227 69 43 13 26
DIAZEPAM 219 32 35 B 14 74
HYDROCHLOROTHIAZIDE 212 95 50 15 14
PROMETHAZINE HCL 205 61 39 R 16 67
SIMVASTATIN 185 98 41 17 4
TRAMADOL HCL 173 23 38 18 15
ENDOCET 160 15 50 S2 19 216
LORAZEPAM 159 41 24 B 20 31
METFORMIN HCL 152 51 36 21 8
OXYCONTIN 148 15 16 S2 22 170
PROAIR HFA 147 18 44 23 42
SERTRALINE HCL 139 37 29 24 30
MORPHINE SULFATE ER 137 15 18 S2 25 141
LEVOTHYROXINE SODIUM 133 36 29 26 3
FUROSEMIDE 126 56 37 27 7
METHOCARBAMOL 125 25 49 R 28 90
AMITRIPTYLINE HCL 116 26 18 R 29 54
MONTELUKAST SODIUM 113 38 23 30 38
TRAZODONE HCL 109 16 19 31 32
AMLODIPINE BESYLATE 107 69 30 32 5
QUETIAPINE FUMARATE 105 19 17 A 33 60
LYRICA 104 26 26 34 49
CYCLOBENZAPRINE HCL 98 15 30 R 35 51
ATENOLOL 94 51 18 36 28
AMOXICILLIN 85 34 70 37 87
POTASSIUM CHLORIDE 85 30 28 37 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 29 25 39 23
RANITIDINE HCL 82 20 21 40 44
CLONIDINE HCL 81 20 17 41 34
PRAVASTATIN SODIUM 81 29 20 41 10
PANTOPRAZOLE SODIUM 72 37 16 43 24
METHYLPREDNISOLONE 72 12 62 43 98
METOPROLOL TARTRATE 70 29 16 45 22
METOPROLOL SUCCINATE 70 29 15 45 21
CLOPIDOGREL 68 25 15 47 25
VENLAFAXINE HCL ER 68 24 11 47 104
ATORVASTATIN CALCIUM 62 31 11 49 9
FAMOTIDINE* 58 24 19 50 95
CYMBALTA 58 <11 16 50 50
AZITHROMYCIN 57 16 49 52 46
IBUPROFEN 55 0 14 53 99
AMPHETAMINE SALT COMBO 50 0 11 S2 54 200
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.